Henry Meds and Zepbound: Tirzepatide Options and Program Model

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This explainer is part of the PlexusDx Education Hub, where we cover GLP-1 medications, weight-management protocols, and the genetic factors that influence every metabolic outcome. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial relationship with Henry Meds or the makers of the brands named here, and no affiliate links or compensation are involved.

Full head-to-head: PlexusDx vs Henry Meds →

Henry Meds is one of many telehealth brands offering GLP-1 medications, and it is often searched next to Zepbound. This review explains what Zepbound is, how it compares to Henry's tirzepatide offering, and where branded and compounded paths diverge. Balanced editorial context, not a buying recommendation, current as of April 2026.

Where Zepbound sits in the GLP-1 landscape

Zepbound is a brand name for tirzepatide, a dual GIP and GLP-1 receptor agonist approved for chronic weight management and delivered by injection. As an FDA-approved branded product, it is manufactured and dispensed through retail pharmacies, a different track from the compounded tirzepatide that some telehealth programs prepare through 503A pharmacies.

Does Henry Meds offer Zepbound?

Oral tirzepatide, not injectable

Henry's tirzepatide is provided only as oral dissolving tablets as of July 2026; it does not offer an injectable tirzepatide, and injectable tirzepatide is precisely the form Zepbound takes. Anyone searching "Henry Meds Zepbound" should know the formats differ. Henry's tablets sell as a three-month supply at $1,047, or $891 paid in full, verified July 20, 2026.

Compounded versus branded tirzepatide

Henry's tirzepatide is compounded through a 503A pharmacy rather than dispensed as branded Zepbound. The two share the tirzepatide molecule but differ in regulatory status, formulation, delivery format, and sourcing. Branded Zepbound carries its own manufacturer pricing, which should be confirmed directly rather than inferred from a compounded rate.

Tirzepatide's mechanism and trial record

Tirzepatide activates both the GIP and GLP-1 receptors, a dual mechanism distinct from single-target GLP-1 agonists like semaglutide. Its principal evidence comes from the SURMOUNT program for weight management, published in The New England Journal of Medicine in 2022, and SURMOUNT-OSA for obstructive sleep apnea, published in NEJM in 2024. Populations, endpoints, and individual outcomes vary.

How Henry prices its tirzepatide option

Because Henry offers tirzepatide only in oral form, its pricing differs from an injectable. The dissolving tablets are a three-month supply at $1,047 ($891 paid in full), with no month-to-month rate. For reference, Henry's injectable compounded semaglutide is $297 per month month-to-month (lower on prepaid plans), and there is no membership or consultation fee, with a free provider evaluation until a prescription is written. Verified July 20, 2026.

The pathway biology behind any weight response

Zepbound and any tirzepatide act on receptors that sit within a genetically shaped system. Variants in GLP1R, FTO, MC4R, and TCF7L2 influence satiety, energy balance, and glucose regulation at the pathway level. They do not predict how you will respond to Zepbound or compounded tirzepatide, but they map the metabolic terrain the compound enters, a layer no telehealth prescription addresses.

PlexusDx adds that layer directly. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including FTO, MC4R, and TCF7L2, so a tirzepatide decision begins with your own baseline biology.

The PlexusDx alternative

PlexusDx offers tirzepatide and semaglutide through its Weight Management Protocols: Tirzepatide Injection, Tirzepatide Oral, Semaglutide Injection, and Semaglutide Oral, each paired with the genetic context most telehealth programs omit.

Not affiliated: PlexusDx is not affiliated with Henry Meds and has no commercial relationship with the companies referenced in this article.

Related reading on PlexusDx: How To Get Zepbound, Injection Zepbound, Microdose Zepbound, Zepbound Alternatives.

Disclaimer: This article is educational. PlexusDx is not affiliated with Henry Meds and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches within the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare the PlexusDx approach: see the Weight Management Protocols, semaglutide and tirzepatide with the genetic context most telehealth programs skip. Or start upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.

Frequently Asked Questions About Henry Meds and Zepbound

Can I get Zepbound through Henry Meds?

Henry offers tirzepatide only as oral dissolving tablets as of July 2026, whereas Zepbound is injectable branded tirzepatide. The formats and regulatory status differ, so Henry's tirzepatide is not the same as branded Zepbound. Confirm exactly what is offered on Henry's official website before deciding.

What is the difference between Zepbound and compounded tirzepatide?

Zepbound is FDA-approved branded tirzepatide dispensed by retail pharmacies as an injection. Compounded tirzepatide is made to prescription through a 503A pharmacy, and Henry provides it as oral tablets. The molecule is shared, but formulation, delivery, sourcing, and regulatory status differ between them.

How is tirzepatide different from semaglutide-based drugs?

Tirzepatide, the molecule in Zepbound, is a dual GIP and GLP-1 receptor agonist, while semaglutide targets the GLP-1 receptor alone. Their trial programs differ too, SURMOUNT for tirzepatide and STEP for semaglutide, with different populations and endpoints. Individual results vary across compounds and people.

Does the genetic test predict my response to Zepbound?

No. The Precision Peptide Genetic Test never predicts response to Zepbound, tirzepatide, or any specific medication. It analyzes pathway-level variants such as FTO and MC4R, and TCF7L2 that describe baseline metabolic biology, context for an informed provider conversation rather than a forecast of drug outcomes.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.